- Home
- LXEO vs KFS Comparison
LXEO vs KFS Comparison
Compare LXEO & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LXEO | KFS |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.8M | 325.8M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LXEO | KFS |
|---|---|---|
| Price | $5.16 | $10.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $18.44 | N/A |
| AVG Volume (30 Days) | ★ 667.0K | 48.4K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $654,000.00 | ★ $134,996,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.42 |
| 52 Week Low | $2.72 | $9.84 |
| 52 Week High | $10.99 | $16.80 |
Technical Indicators
Market Signals| Indicator | LXEO | KFS |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 43.54 |
| Support Level | $4.95 | $10.00 |
| Resistance Level | $6.26 | $12.06 |
| Average True Range (ATR) | 0.38 | 0.53 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 36.34 | 30.69 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The company generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.